Union Cycliste Internationale
English  |  Français  
News ▪
Home Road Track Mountain Bike Cyclo-cross BMX Trials Indoor cycling Para-cycling Cycling for all
News
Agrandir le texte Réduire le texte Imprimer la page Envoyer l'article

Title:

Press release: Adverse Analytical Finding for Sylvain Georges

Date:

15.05.2013

Description:

Earlier today the UCI notified French rider Sylvain Georges of an Adverse Analytical Finding (presence of the stimulant Heptaminol based on the analysis report from the WADA accredited laboratory in Roma) in his urine sample collected at the Giro d’Italia on 10 May 2013.

Mr Georges has the right to request and attend the analysis of his B sample.

The UCI Anti-Doping Rules do not impose a provisional suspension given the nature of the substance, which is a specified substance.


Under the World Anti-Doping Code and the UCI Anti-Doping Rules, the UCI is unable to provide any additional information at this time.


UCI Communication Service

Characteristics:
Back
  Publications  Links  Employment  FAQ  Contacts  RSS